Dr. Keith Jason August, MD
- Part D claims, 2024
- 21
- Publications
- 42
- Clinical trials
- 11
- Industry payments
- $32,746
- Affiliated sites
- 1
- Practice address
- 2401 Gillham Rd, Kansas City, MO 64108
- Practice phone
- Call (816) 234-3100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Children's Mercy Dialysis Program
Dialysis Center - Hospital-Based · Kansas City, Missouri
Find Dr. August's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Keith Jason August is a pediatric hematology and oncology physician in Kansas City, Missouri
Dr. August practices at Children's Mercy Dialysis Program in Kansas City, Missouri.
Dr. August's NPI, 1669554085, was assigned on October 19, 2006. Dr. August holds Missouri license 2009026148.
- NPI
- 1669554085NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3173669926
- NPI enumeration date
- October 19, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (816) 234-3100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Keith Jason August practices at Children's Mercy Dialysis Program in Kansas City, Missouri
Dr. August's primary practice is Children's Mercy Dialysis Program, at 2401 Gillham Rd, Kansas City, MO 64108 in Jackson County. The practice phone is (816) 234-3100.
- Children's Mercy Dialysis Program2401 Gillham Rd, Kansas City, MO 64108 · Jackson CountyPhone(816) 234-3100
Source: Dmand AI Affiliation Data
Dr. Keith Jason August is affiliated with 1 site of care and 1 medical group
Dr. August's primary practice is Children's Mercy Dialysis Program in Kansas City, Missouri. The medical group on file is Children's Mercy. Dr. August's employer is on file too: a dialysis center.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Keith Jason August's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. August practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Children's Mercy Dialysis Program | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Keith Jason August is one of 78 pediatric hematologys and oncology physicians in Missouri
Pediatric hematology-oncology is Dr. August's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. August's licenses on file in 2 states: Missouri and Kansas.
Specialties and state licenses
- Pediatric hematology and oncology, MissouriPrimary
- Kansas license
Pediatric hematologys and oncology physicians near Dr. August
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Keith Jason August's patients have a median age of 12
Across all payers, Dmand AI patient panel data puts Dr. August's median patient age at 12, with 50% women.
Dr. August's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 12
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. Keith Jason August wrote 21 Medicare Part D claims in 2024
In 2024, Dr. August wrote 21 Medicare Part D claims. 95% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $23 in total drug cost. In 2023, CMS named 12 claims across 1 drug.
Dr. August's Part D claims by kind of drug, 2024
- Generic20 claims95%
- Brand-name and other1 claims5%
Dr. August's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 122024: 138%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Keith Jason August takes part in Medicare
Dr. August accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Keith Jason August has 42 publications on record
Dmand AI links 42 papers to Dr. August, published from 2010 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma and Receptors, Antigen, T-Cell. Dr. August has published most often in Pediatr Blood Cancer. Dr. August's most frequent co-authors are Michael Wayne Boyer, MD, Stephan A. Grupp, MD and Erin Marie Guest, MD.
Dr. August's papers by year, 2011 to 2024
Topics Dr. August writes about most
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Receptors, Antigen, T-Cell
- Antineoplastic Combined Chemotherapy Protocols
- Immunotherapy, Adoptive
- In Situ Hybridization, Fluorescence
- Lymphoma, Large B-Cell, Diffuse
- Antigens, CD19
Dr. August's most frequent co-authors
- Michael Wayne Boyer, MD4 shared papers
- Stephan A. Grupp, MD4 shared papers
- Erin Marie Guest, MD4 shared papers
Recent publications by Dr. August
Novel thermoplastic microvalves based on an elastomeric cyclic olefin copolymer (opens in a new tab)
Lab Chip
BMC Med Res Methodol
See who Dr. August researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. August works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Keith Jason August has worked on 11 clinical trials
Dmand AI links Dr. August to 11 clinical trials, 8 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Central Nervous System Neoplasms, Down Syndrome and Fibrolamellar hepatocellular carcinoma. Children's Oncology Group sponsors the most, 7. Open Payments lists research payments to Dr. August that name 1 trial.
Clinical trials with Dr. August by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 8Phase 3: 8 trials
- NonePhase 4: no trials
Conditions in Dr. August's trials
- Central Nervous System Neoplasms
- Down Syndrome
- Fibrolamellar hepatocellular carcinoma
- Hodgkin Disease
- Leukemia, Biphenotypic, Acute
Investigators on the most trials with Dr. August
- Douglas S. Hawkins9 shared trials
- David L. Becton, MD8 shared trials
- Judy Linn Felgenhauer, MD8 shared trials
Recent clinical trials with Dr. August
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma (opens in a new tab)
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (opens in a new tab)
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma (opens in a new tab)
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Keith Jason August received $32,746 in industry payments from 2016 to 2024
CMS Open Payments shows 37 general payments to Dr. August from 5 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 64% of the total. Novartis Pharmaceuticals Corporation paid the most, $25,392. It also lists 4 research payments totaling $2,247 from 2016 to 2019, naming 1 clinical trial.
General payments to Dr. August by program year, 2016 to 2024
General payments to Dr. August by kind, 2016 to 2024
- Speaker and faculty fees$21,06064%
- Consulting fees$6,52520%
- Travel and lodging$3,84312%
- Food and beverage$1,3184%
Companies that paid Dr. August the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Keith Jason August's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Keith Jason August
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Keith Jason August's NPI number?
Dr. Keith Jason August's NPI number is 1669554085. It was assigned on October 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Keith Jason August?
Dr. Keith Jason August is a pediatric hematology and oncology physician in Kansas City, Missouri. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Keith Jason August practice?
Dr. August practices at 2401 Gillham Rd, Kansas City, MO 64108. Dr. August's primary practice is Children's Mercy Dialysis Program in Kansas City, Missouri.
What is Dr. Keith Jason August's office phone number?
The practice phone on file for Dr. August is (816) 234-3100.
What is Dr. Keith Jason August's medical license number?
Dr. August holds Missouri license 2009026148, one of the licenses on file in 2 states.
Which states has Dr. Keith Jason August been licensed in?
Dmand AI has state licenses on file for Dr. August in Missouri and Kansas.
What medical group is Dr. Keith Jason August part of?
Dr. August is linked to Children's Mercy.
Does Dr. Keith Jason August accept Medicare?
Yes. CMS lists Dr. August as accepting Medicare assignment.
What drugs does Dr. Keith Jason August prescribe most?
In 2024 Medicare Part D data, Dr. August's most prescribed drugs by claims were Omeprazole.
Has Dr. Keith Jason August received payments from drug or device companies?
CMS Open Payments shows $32,746 in general payments to Dr. August from 5 companies from 2016 to 2024. The largest total came from Novartis Pharmaceuticals Corporation.
Show 3 more questionsShow fewer questions
How long has Dr. Keith Jason August been practicing?
Dr. August's NPI was assigned in 2006.
Does Dr. Keith Jason August do research?
Dmand AI links 42 publications to Dr. August, published from 2010 to 2024. Dr. August has worked on 11 clinical trials.
Who does Dr. Keith Jason August publish with?
Dr. August's most frequent co-authors are Michael Wayne Boyer, MD (4 shared papers), Stephan A. Grupp, MD (4 shared papers) and Erin Marie Guest, MD (4 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Missouri by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card